Skip to main content
CATCongressional Accountability Tracker
OfficialsLegislationCommitteesWatch LivePulseForecastMisconductPresidentLearn
CAT

Congressional Accountability Tracker. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Forecast

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live
  • About This Site

Data Sources

Congress.gov
Bills, members, votesGovInfo
Floor speeches, reports, bill textFederal Election Commission
Campaign financeVoteView
Ideology scores (DW-NOMINATE)GovTrack
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Congressional Accountability Tracker

Press Release2026-03-20

Vindman, Pfluger, & Baumgartner Introduce Legislation to Protect Americans and Combat Deadly Nitazenes

Eugene Simon Vindman
Eugene Simon Vindman
DVA-7 · Representative
Share:

Full Text

Vindman, Pfluger, & Baumgartner Introduce Legislation to Protect Americans and Combat Deadly Nitazenes

Washington, D.C. — U.S. Representatives Eugene Vindman (D-Va.-07), August Pfluger (R-Texas-11), Michael Baumgartner (R-Wash.-05) introduced a bipartisan bill to address the alarming rise in nitazenes, a new class of synthetic opioids that are stronger and deadlier than fentanyl. This bipartisan, bicameral legislation directs the Department of Homeland Security’s (DHS) Science and Technology Directorate to coordinate with the Drug Enforcement Administration (DEA) to enhance technologies […]
View original source →